Smith & Nephew plc vs NEOS S&P 500 High Income ETF — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while NEOS S&P 500 High Income ETF trades at $53.42. The key difference: Smith & Nephew plc pays a 2.57% dividend while NEOS S&P 500 High Income ETF pays none, and NEOS S&P 500 High Income ETF is trading nearer its 52-week high, Smith & Nephew plc nearer its low. Which is the better fit depends on your goals.
| SNN | SPYI | |
|---|---|---|
Market Cap | $12.64B | — |
Sector | Health | Income / Options Overlay |
52-Week High | $38.70 | $54.07 |
52-Week Low | $28.73 | $47.98 |
Enterprise Value | $15.41B | — |
Dividend Yield | 2.57% | — |
Trailing returns across standard periods
Latest headlines on both assets
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.
Read more on SPYI →